Related Experiment Video
Updated: Oct 12, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Meropenem resistance in Pseudomonas aeruginosa
1Discovery Research Laboratories III, Sumitomo Pharmaceuticals, Osaka, Japan.
Abstract:
Two genetically distinct classes of meropenem-low-susceptibility Pseudomonas aeruginosa PAO2152 mutants, which arose spontaneously, were isolated. Two meropenem resistance genes, mpmA and mpmB, were mapped near ilvB/C and proC, respectively, on the P. aeruginosa PAO chromosome. The mpmA was thought to be identical to oprD2 because of the cross-resistance to carbapenems and the association with the loss of the outer membrane protein D2 (OprD2). The mpmB mutation conferred a 4-fold increase in resistance to meropenem, and cross-resistance to various types of antimicrobial agents, e.g. carbenicillin, norfloxacin and chloramphenicol. However, the mpmB mutant was susceptible to imipenem. This mutant still possessed OprD2 and showed increased expression of a 48-kD outer membrane protein, although its profiles of beta-lactamase activity and affinities of penicillin-binding proteins for beta-lactams were indistinguishable from those of the parent strain. The resistance gene mpmB was considered to be an allele of nalB (or cfxB or oprK) from the results of the transductional analysis. The mutation frequency of mpmA:mpmB was in the ratio of 4:1. The same results were obtained in another clinically isolated P. aeruginosa strain. Meropenem resistance caused by both mpmA and mpmB mutations seemed to be due to the reduction in permeability of antibiotics through the outer membrane. These findings suggest a new pathway for the translocation of meropenem other than that mediated by OprD2 across the outer membrane. Thus, meropenem showed about 4- to 8-fold higher activity than imipenem against OprD2-deficient P. aeruginosa.
Insights
Two Pseudomonas aeruginosa genes, mpmA and mpmB, confer low susceptibility to meropenem by reducing antibiotic permeability. This discovery suggests novel meropenem translocation pathways beyond OprD2.
Area of Science:
- Microbiology
- Genetics
- Pharmacology
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen known for its intrinsic and acquired resistance to antibiotics.
- Meropenem is a critical carbapenem antibiotic used to treat serious infections caused by Gram-negative bacteria.
- Understanding the mechanisms of meropenem resistance is crucial for developing effective treatment strategies.
Purpose of the Study:
- To identify and characterize the genetic basis of spontaneous meropenem resistance in Pseudomonas aeruginosa.
- To elucidate the specific mutations and their impact on antibiotic susceptibility and outer membrane protein expression.
- To investigate potential novel pathways for meropenem translocation across the bacterial outer membrane.
Main Methods:
- Isolation and characterization of meropenem-low-susceptibility Pseudomonas aeruginosa PAO2152 mutants.
- Genetic mapping of resistance genes (mpmA and mpmB) on the bacterial chromosome.
- Analysis of outer membrane protein profiles, beta-lactamase activity, and penicillin-binding protein affinities.
- Transductional analysis to determine the allelic relationship of resistance genes.
Main Results:
- Two distinct classes of meropenem-resistant mutants were identified, linked to mpmA and mpmB genes.
- mpmA mutation was associated with the loss of outer membrane protein D2 (OprD2), conferring cross-resistance to carbapenems.
- mpmB mutation increased meropenem resistance 4-fold, with cross-resistance to other agents but susceptibility to imipenem, and was linked to nalB/cfxB/oprK.
- Both mutations appeared to reduce antibiotic permeability through the outer membrane, suggesting alternative meropenem translocation routes.
Conclusions:
- Meropenem resistance in P. aeruginosa can arise from mutations in mpmA (linked to OprD2) and mpmB (an allele of nalB/cfxB/oprK).
- These mutations likely reduce antibiotic permeability, indicating potential novel translocation pathways for meropenem independent of OprD2.
- Meropenem exhibits significantly higher activity than imipenem against OprD2-deficient P. aeruginosa strains.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

